Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cathie Wood’s flagship fund, the ARK Innovation (NYSEARCA: ARKK ) exchange-traded fund (ETF), has lost over 50% since the year began. However, investors still seem to be confident in ARK Invest’s activ...
ATAI is backed by Peter Thiel. Its decentralized business model is pretty unique. I will wait for more data before I take a call on this very interesting company. Atai Life Sciences N.V. ( ATAI ) is a German-headquartered developer of medicines for mental health diso...
Tech stocks have crashed, but Wall Street should eventually remember why the love affair began in the first place. After the tech crash, it makes sense to invest in a large quantity of names. Even so, this isn't an excuse to buy anything and everything. Don’t waste your tim...
Kures Therapeutics, an atai Life Sciences ( NASDAQ: ATAI ) appoints of Chad E. Beyer, Ph.D., MBA, as CEO of Kures succeeding Dr. Srinivas Rao, effective July 1, 2022. Dr. Srinivas Rao will continue to support and advise Kures’ pro...
NEW YORK, June 30, 2022 (GLOBE NEWSWIRE) -- Kures Therapeutics, Inc (“Kures”), an atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”) company focused on developing treatment options to better manage addictions, depression, and pain, today announced the appointment of...
The stock market has been tough over the last month, as has most of the U.S. economy. The Federal Reserve raised interest rates by 0.75 percent on Wednesday, June 15, and that reduces the amount of money in the economy. Besides mortgages, rising interest rates impact...
atai Life Sciences (NASDAQ:ATAI) announced Stephen Bardin appionted as the as the CFO during the 3Q22. Initially, Mr. Bardin will join the company as Deputy CFO and CFO Designate on June 27th and will be supported in his transition by current CFO Greg Weaver. Mr....
Stephen Bardin will join as CFO Designate on June 27, 2022 After a transition period, atai’s current CFO Greg Weaver will be moving into a part time strategic advisory role NEW YORK and BERLIN, June 17, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V., (Nasdaq: ATAI) (...
NEW YORK and BERLIN, June 16, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in the following upcoming healthcare conferences in...
Editors Note: This story was originally published on June 13, but due to some technical problems we had to reset the website and as a result, the story got erased. This is the same story but republished. Biotechnology is always a dicey business to create, run, and make p...
News, Short Squeeze, Breakout and More Instantly...
ATAI Life Sciences N.V. Company Name:
ATAI Stock Symbol:
NASDAQ Market:
ATAI Life Sciences N.V. Website:
Alcohol use disorder is a disorder characterized by an inability to stop or control one’s drinking despite adverse health, occupational or social consequences. Conventional treatments include medication, behavioral therapy, and support groups. Even with these treatments, however, many ind...
Psychedelics such as DMT, LSD and psilocybin have demonstrated promise in the treatment of affective symptoms of a range of disorders. These drugs work by inducing an altered state of consciousness , which includes intensified perceptions and emotions, which have been associated with therapeutic...